These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 25659102
21. Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation. Wojtas AM, Carlomagno Y, Sens JP, Kang SS, Jensen TD, Kurti A, Baker KE, Berry TJ, Phillips VR, Castanedes MC, Awan A, DeTure M, De Castro CHF, Librero AL, Yue M, Daughrity L, Jansen-West KR, Cook CN, Dickson DW, Petrucelli L, Fryer JD. Acta Neuropathol Commun; 2020 Dec 01; 8(1):210. PubMed ID: 33261653 [Abstract] [Full Text] [Related]
23. Tau Fibril Formation in Cultured Cells Compatible with a Mouse Model of Tauopathy. Matsumoto G, Matsumoto K, Kimura T, Suhara T, Higuchi M, Sahara N, Mori N. Int J Mol Sci; 2018 May 17; 19(5):. PubMed ID: 29772786 [Abstract] [Full Text] [Related]
25. Endogenous tau aggregates in oligodendrocytes of rTg4510 mice induced by human P301L tau. Ren Y, Lin WL, Sanchez L, Ceballos C, Polydoro M, Spires-Jones TL, Hyman BT, Dickson DW, Sahara N. J Alzheimers Dis; 2014 May 17; 38(3):589-600. PubMed ID: 24028867 [Abstract] [Full Text] [Related]
26. Tau local structure shields an amyloid-forming motif and controls aggregation propensity. Chen D, Drombosky KW, Hou Z, Sari L, Kashmer OM, Ryder BD, Perez VA, Woodard DR, Lin MM, Diamond MI, Joachimiak LA. Nat Commun; 2019 Jun 07; 10(1):2493. PubMed ID: 31175300 [Abstract] [Full Text] [Related]
28. Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice. Stancu IC, Vasconcelos B, Ris L, Wang P, Villers A, Peeraer E, Buist A, Terwel D, Baatsen P, Oyelami T, Pierrot N, Casteels C, Bormans G, Kienlen-Campard P, Octave JN, Moechars D, Dewachter I. Acta Neuropathol; 2015 Jun 07; 129(6):875-94. PubMed ID: 25862635 [Abstract] [Full Text] [Related]
30. Screening of a neuronal cell model of tau pathology for therapeutic compounds. Pickhardt M, Tassoni M, Denner P, Kurkowsky B, Kitanovic A, Möhl C, Fava E, Mandelkow E. Neurobiol Aging; 2019 Apr 07; 76():24-34. PubMed ID: 30640040 [Abstract] [Full Text] [Related]
32. Brief update on different roles of tau in neurodegeneration. Ittner A, Ke YD, van Eersel J, Gladbach A, Götz J, Ittner LM. IUBMB Life; 2011 Jul 07; 63(7):495-502. PubMed ID: 21698753 [Abstract] [Full Text] [Related]
34. The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties. Matsumoto SE, Motoi Y, Ishiguro K, Tabira T, Kametani F, Hasegawa M, Hattori N. Hum Mol Genet; 2015 Nov 15; 24(22):6403-16. PubMed ID: 26374846 [Abstract] [Full Text] [Related]
35. Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model. Ando K, Leroy K, Heraud C, Kabova A, Yilmaz Z, Authelet M, Suain V, De Decker R, Brion JP. Biochem Soc Trans; 2010 Aug 15; 38(4):1001-5. PubMed ID: 20658993 [Abstract] [Full Text] [Related]
39. The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition. Eskandari-Sedighi G, Daude N, Gapeshina H, Sanders DW, Kamali-Jamil R, Yang J, Shi B, Wille H, Ghetti B, Diamond MI, Janus C, Westaway D. Mol Neurodegener; 2017 Oct 04; 12(1):72. PubMed ID: 28978354 [Abstract] [Full Text] [Related]
40. Homocysteine Increases Tau Phosphorylation, Truncation and Oligomerization. Shirafuji N, Hamano T, Yen SH, Kanaan NM, Yoshida H, Hayashi K, Ikawa M, Yamamura O, Kuriyama M, Nakamoto Y. Int J Mol Sci; 2018 Mar 17; 19(3):. PubMed ID: 29562600 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]